Hana Pharm Co Ltd Cash Flow Quality Index
Hana Pharm Co Ltd cash flow quality index. Hana Pharm Co Ltd (293480) has a Cash Flow Quality Index of 0.82x as of June 2026. Operating cash flow of ₩6.91 Billion is below net income of ₩8.45 Billion, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Hana Pharm Co Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hana Pharm Co Ltd (2016–2025)
Cash flow quality index of Hana Pharm Co Ltd from 2016 to 2025. Historical Cash Flow Quality Index for Hana Pharm Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Hana Pharm Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Hana Pharm Co Ltd Cash Flow Quality Index by Year (2016–2025)
Hana Pharm Co Ltd cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Hana Pharm Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Hana Pharm Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.05x | ₩9.18 Billion | ₩8.78 Billion | ▼ -12.2% |
| 2024 | 1.19x | ₩25.30 Billion | ₩21.25 Billion | ▲ +44.5% |
| 2023 | 0.82x | ₩18.40 Billion | ₩22.33 Billion | ▼ -35.1% |
| 2022 | 1.27x | ₩30.88 Billion | ₩24.31 Billion | ▲ +38.7% |
| 2021 | 0.92x | ₩25.66 Billion | ₩28.01 Billion | ▼ -12.5% |
| 2020 | 1.05x | ₩15.58 Billion | ₩14.89 Billion | ▼ -6.6% |
| 2019 | 1.12x | ₩31.72 Billion | ₩28.30 Billion | ▲ +6.3% |
| 2018 | 1.05x | ₩27.59 Billion | ₩26.17 Billion | ▲ +0.9% |
| 2017 | 1.04x | ₩25.38 Billion | ₩24.30 Billion | ▲ +46.0% |
| 2016 | 0.72x | ₩12.46 Billion | ₩17.43 Billion | — |